Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics.
Ontology highlight
ABSTRACT: Fibrogenic processes instigate fatal chronic diseases leading to organ failure and death. Underlying biological processes involve induced massive deposition of extracellular matrix (ECM) by aberrant fibroblasts. We subjected diseased primary human lung fibroblasts to an advanced three-dimensional phenotypic high-content assay and screened a repurposing drug library of small molecules for inhibiting ECM deposition. Fibrotic Pattern Detection by Artificial Intelligence identified tranilast as an effective inhibitor. Structure-activity relationship studies confirmed N-(2-butoxyphenyl)-3-(phenyl)acrylamides (N23Ps) as a novel and highly potent compound class. N23Ps suppressed myofibroblast transdifferentiation, ECM deposition, cellular contractility, and altered cell shapes, thus advoca
SUBMITTER: Gerckens M
PROVIDER: S-EPMC8694600 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA